Immucell (ICCC) Current Deferred Tax Assets (2011 - 2015)
Immucell (ICCC) recorded Current Deferred Tax Assets of $69,011 in Q3 2015, up 25.3% from the prior quarter.
Analysis
Immucell (ICCC) Current Deferred Tax Assets (2011 - 2015) Analysis & Trends
At the end of FY2014, Immucell reported Current Deferred Tax Assets of $30,463, up 100.3% from FY2013.
- Annual Current Deferred Tax Assets has a three-year compound annual growth rate of -19.8% (FY2011 to FY2014).
- Across earlier years, Current Deferred Tax Assets came in at $15,212 in FY2013 (-51.2%), $31,177 in FY2012 (-47.2%) and $59,016 in FY2011.
- The Q3 2015 figure is the highest quarterly Current Deferred Tax Assets in data going back to Q2 2011.
- On a year-over-year basis, Current Deferred Tax Assets rose in three of the last four quarters, with growth averaging 88.0%.
- Peak year-over-year performance for Current Deferred Tax Assets in the last five years was growth of 225.7% in Q1 2014, against a decline of 91.7% in Q1 2013 at the low end.
- Per Business Quant, the preceding three quarters came in at $55,087 (Q2 2015), $17,673 (Q1 2015) and $30,463 (Q4 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.52 Bn | 1,100.11 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.33 Bn | 534.86 Bn | 17.26 Bn |
| 3 | AbbVie | 500.08 Bn | 473.19 Bn | 12.70 Bn |
| 4 | Merck | 366.80 Bn | 321.17 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.59 Bn | 235.28 Bn | 12.86 Bn |
| 7 | Amgen | 234.86 Bn | 190.26 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 189.95 Bn | 164.15 Bn | 6.22 Bn |
| 9 | Pfizer | 169.63 Bn | 116.28 Bn | 10.94 Bn |
| 10 | Immucell | 94.27 Mn | 71.72 Mn | 2.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 69,011.00 |
| Jun 30, 2015 | 55,087.00 |
| Mar 31, 2015 | 17,673.00 |
| Dec 31, 2014 | 30,463.00 |
| Mar 31, 2014 | 9,976.00 |
| Dec 31, 2013 | 15,212.00 |
| Sep 30, 2013 | 16,074.00 |
| Jun 30, 2013 | 19,350.00 |
| Mar 31, 2013 | 3,063.00 |
| Dec 31, 2012 | 31,177.00 |
| Sep 30, 2012 | 33,150.00 |
| Jun 30, 2012 | 19,213.00 |
| Mar 31, 2012 | 36,796.00 |
| Dec 31, 2011 | 59,016.00 |
| Sep 30, 2011 | 45,516.00 |
| Jun 30, 2011 | 13,376.00 |
API Access
Immucell Current Deferred Tax Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-tax-assets", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();